Original paper<br>

Magdalena Kumor; Elżbieta K. Biernacka; Marcin Demkow; Marek Konka; Anna E. Płatek; Michalina Jagodzińska; Piotr Hoffman

doi:10.5114/pwki.2014.45141

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2014
vol. 10

Send email

Copy url:

abstract:

Original paper
"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism

Magdalena Kumor

,

Elżbieta K. Biernacka

,

Marcin Demkow

,

Marek Konka

,

Anna E. Płatek

,

Michalina Jagodzińska

,

Piotr Hoffman

Postep Kardiol Inter 2014; 10, 3 (37): 155–160

DOI: https://doi.org/10.5114/pwki.2014.45141

Online publish date: 2014/09/11

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Kumor M, Biernacka E, Demkow M, et al. Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2014;10(3):155-160. doi:10.5114/pwki.2014.45141.

APA

Kumor, M., Biernacka, E., Demkow, M., Konka, M., Płatek, A.,  & Jagodzińska, M. et al. (2014). Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 10(3), 155-160. https://doi.org/10.5114/pwki.2014.45141

Chicago

Kumor, Magdalena, Elżbieta K. Biernacka, Marcin Demkow, Marek Konka, Anna E. Płatek, Michalina Jagodzińska,  and Piotr Hoffman. 2014. "Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 10 (3): 155-160. doi:10.5114/pwki.2014.45141.

Harvard

Kumor, M., Biernacka, E., Demkow, M., Konka, M., Płatek, A., Jagodzińska, M.,  and Hoffman, P. (2014). Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 10(3), pp.155-160. https://doi.org/10.5114/pwki.2014.45141

MLA

Kumor, Magdalena et al. "Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 10, no. 3, 2014, pp. 155-160. doi:10.5114/pwki.2014.45141.

Vancouver

Kumor M, Biernacka E, Demkow M, Konka M, Płatek A, Jagodzińska M et al. Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2014;10(3):155-160. doi:10.5114/pwki.2014.45141.

Introduction: Patent foramen ovale (PFO) is associated with cryptogenic strokes, recurrent transient neurologic deficits, sleep apnea, decompression illness and migraines with aura.

Aim: We verify cryptogenic embolism recurrence after transcatheter PFO closure in patients younger than 55 years old, and determine the prevalence of migraine with aura before and after PFO closure.

Material and methods: We sent a questionnaire concerning the recurrence of stroke or transient ischemic attack (TIA) and the presence of migraine symptoms before and after PFO closure to 224 consecutive patients (mean age 40.9 ±9 years; 103 men; 108 patients < 40 years old, 116 patients 40–55 years old) after successful PFO transcatheter closure as secondary prevention of cryptogenic embolism.

Results: The mean follow-up period was 37.8 ±32.5 (median 27) months. Stroke or TIA recurred in 6 patients (2.6%), all of whom were over 40 years old at the time of closure. The median time of recurrence was 24 months. Two patients (0.89%) died, but the deaths were not related to the device nor to thromboembolism. Migraine occurred in the study group before closure in 68 (30.4%) patients. After the procedure 55 (80.9%) reported improvement or disappearance of migraine symptoms.

Conclusions: Recurrent strokes after PFO closure are rare, and they occur more often in patients over 40 years old at the time of closure. The PFO closure results in migraine subsiding or symptoms noticeably ameliorating.

Original paper"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism

Magdalena Kumor , Elżbieta K. Biernacka , Marcin Demkow , Marek Konka , Anna E. Płatek , Michalina Jagodzińska , Piotr Hoffman

Original paper
"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism

Magdalena Kumor

,

Elżbieta K. Biernacka

,

Marcin Demkow

,

Marek Konka

,

Anna E. Płatek

,

Michalina Jagodzińska

,

Piotr Hoffman